Exploring the biological functions and immune regulatory roles of IRAK3, TNFRSF1A, CX3CR1, and JUNB in T2DM combined with MAFLD: integrated bioinformatics and single-cell analysis

Sep 8, 2025Frontiers in immunology

Biological and immune roles of IRAK3, TNFRSF1A, CX3CR1, and JUNB in type 2 diabetes with fatty liver disease using bioinformatics and single-cell analysis

AI simplified

Abstract

Four key IRAK3, TNFRSF1A, CX3CR1, and JUNB—exhibited significantly higher mRNA expression levels in T2DM and MAFLD rat liver tissues compared to controls.

  • Elevated protein levels of IRAK3, TNFRSF1A, CX3CR1, and JUNB were observed in liver tissues of rats with T2DM and MAFLD.
  • Pathways associated with T2DM combined with MAFLD include NF-kappa B signaling, MAPK signaling, and insulin resistance.
  • Correlative analysis indicated connections between immune cell infiltration and the identified biomarkers.
  • Single-cell analysis revealed differentiation patterns of specific genes within various liver cell populations.
  • Pseudo-temporal analysis highlighted key genes linked to pathways involved in immune response and lipid metabolism.

AI simplified

Key numbers

P < 0.05
Increase in mRNA Expression Levels
Comparison of mRNA levels in rat liver tissues
0.8
Values for Diagnostic Accuracy
values for IRAK3, TNFRSF1A, CX3CR1, and JUNB

Key figures

Figure 1
Gene expression patterns and differences in , , and versus controls
Highlights distinct gene expression profiles and clustering differences in T2DM and NASH compared to controls, spotlighting disease-specific molecular changes.
fimmu-16-1587225-g001
  • Panels A–C
    plots showing sample clustering for Control vs T2DM (A), Control vs SS (B), and Control vs NASH (C); T2DM and NASH groups appear visibly separated from controls, while SS shows some overlap.
  • Panels D–F
    Volcano plots of differentially expressed mRNAs in Control vs T2DM (D), Control vs SS (E), and Control vs NASH (F) with points colored by upregulated, downregulated, or not significant genes.
  • Panels G–H
    of the top 40 (DEGs) in GSE15653 (G) and GSE89632 datasets (H), showing gene expression levels across samples with red indicating upregulation and blue downregulation.
Figure 2
Sample clustering, network connectivity, gene , and module-trait associations in samples
Frames gene co-expression patterns and their clinical associations in NASH samples for identification
fimmu-16-1587225-g002
  • Panels A and E
    Sample showing clustering of samples with outliers above a red cutoff line
  • Panels B and F
    Plots of scale-free fit indices and average connectivity for different soft-thresholding powers
  • Panels C and G
    Gene dendrograms with colored modules representing clusters of co-expressed genes after merging similar modules
  • Panels D and H
    of module-trait relationships showing correlations between gene modules and clinical traits
Figure 3
Protein interaction networks and key gene characteristics in combined with MAFLD datasets
Highlights consistent and their interactions across datasets, spotlighting gene correlations in T2DM combined with MAFLD
fimmu-16-1587225-g003
  • Panel A
    showing intersections of top 15 genes identified by MCC, MNC, and Degree algorithms across datasets and
  • Panels B and C
    Protein-Protein Interaction () networks for GSE89632_SS (B) and GSE89632_NASH (C) with genes arranged in circular layouts
  • Panels D–F
    PPI networks for GSE89632_SS showing top 15 genes identified by MCC (D), MNC (E), and Degree (F) algorithms with nodes colored by intensity
  • Panels H–J
    PPI networks for GSE89632_NASH showing top 15 genes identified by MCC (H), MNC (I), and Degree (J) algorithms with nodes colored by intensity
  • Panels G and K
    Venn diagrams showing intersections of genes identified by MCC, MNC, and Degree algorithms in GSE89632_SS (G) and GSE89632_NASH (K), highlighting 13 common hub genes
  • Panels L and M
    of 13 hub genes in GSE89632_SS (L) and GSE89632_NASH (M) datasets displayed on circular chromosome maps
  • Panels N and O
    Correlation of 13 hub genes in GSE89632_SS (N) and GSE89632_NASH (O) datasets showing gene-gene correlation coefficients with significance markers
Figure 4
Machine learning screening and validation of genes in combined with MAFLD datasets
Highlights strong biomarker prediction performance with higher values in T2DM combined with MAFLD datasets
fimmu-16-1587225-g004
  • Panels A and F
    plotted against Log(λ) for parameter selection in datasets and
  • Panels B and G
    Lasso regression coefficient paths for 13 across Log(λ) values in datasets GSE89632_SS and GSE89632_NASH
  • Panels C and H
    Boxplots showing importance Z-scores of features selected by in datasets GSE89632_SS and GSE89632_NASH
  • Panels D and I
    10-fold cross-validation accuracy for different numbers of features in datasets GSE89632_SS and GSE89632_NASH
  • Panels E and J
    Venn diagrams (Wayne plots) showing overlap of feature genes selected by Lasso, , Boruta, and gene sets in datasets GSE89632_SS and GSE89632_NASH
  • Panel K
    ROC curves for IRAK3, TFRC, and TNFRSF1A in dataset GSE89632_SS with AUC values indicating prediction performance
  • Panel L
    ROC curves for JUNB and CX3CR1 in dataset GSE89632_NASH with AUC values indicating prediction performance
  • Panels M to O
    ROC curves for IRAK3, TFRC, TNFRSF1A, CX3CR1, and JUNB in external datasets GSE15653, GSE24807, and GSE23343 showing varied AUC values
Figure 5
Functional enrichment of gene pathways and hub gene involvement in and groups
Highlights distinct pathway enrichments and hub gene associations in combined with MAFLD subgroups, spotlighting NF-kappa B signaling in
fimmu-16-1587225-g005
  • Panels A and B
    Lollipop diagrams display and pathway enrichment for GSE89632_SS (A) and GSE89632_NASH (B) groups, with counts shown by circle size and pathways including NF-kappa B signaling and lipid and atherosclerosis
  • Panels C and D
    show pathway enrichment of in GSE89632_SS (C) and GSE89632_NASH (D) groups, highlighting involvement of genes like TNFRSF1A and JUNB in pathways such as MAPK signaling and lipid and atherosclerosis
1 / 5

Full Text

What this is

  • The study investigates the interplay between Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), focusing on -related .
  • Using bioinformatics and single-cell analysis, it identifies key genes associated with these conditions.
  • The findings aim to enhance understanding of disease mechanisms and improve diagnostic and therapeutic strategies.

Essence

  • Four key —IRAK3, TNFRSF1A, CX3CR1, and JUNB—are identified as significant in T2DM combined with MAFLD. Their elevated expression levels correlate with disease progression and immune regulation.

Key takeaways

  • Elevated mRNA expression levels of IRAK3, TNFRSF1A, CX3CR1, and JUNB were found in T2DM and MAFLD rat liver tissues compared to controls.
  • The study establishes a connection between immune cell infiltration and the identified , suggesting their role in disease mechanisms.
  • Single-cell analysis reveals distinct cellular communication pathways, emphasizing the complex interactions among immune cells in T2DM and MAFLD.

Caveats

  • The study's findings are limited by the relatively small sample size of human datasets, which may affect the generalizability of results.
  • Methodological limitations in single-cell analysis may restrict understanding of dynamic gene modulation during MAFLD progression.

Definitions

  • autophagy: A cellular process that degrades and recycles cellular components, crucial for maintaining homeostasis.
  • biomarker: A biological indicator used to measure and evaluate the presence or progress of a disease.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free